Your browser doesn't support javascript.
loading
Depression and Anxiety Symptoms in Headache Disorders: An Observational, Cross-Sectional Study.
Mantonakis, Leonidas; Belesioti, Ioanna; Deligianni, Christina I; Natsis, Vasilis; Mitropoulou, Euthimia; Kasioti, Elina; Lypiridou, Maria; Mitsikostas, Dimos D.
Affiliation
  • Mantonakis L; First Psychiatry Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
  • Belesioti I; First Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
  • Deligianni CI; First Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
  • Natsis V; Neurology Department, Athens Naval Hospital, Deinokratous 70, 11521 Athens, Greece.
  • Mitropoulou E; First Psychiatry Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
  • Kasioti E; First Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
  • Lypiridou M; First Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
  • Mitsikostas DD; First Neurology Department, Aeginition Hospital, Medical School, National & Kapodistrian University of Athens, V. Sofia's Avenue 74, 11528 Athens, Greece.
Neurol Int ; 16(2): 356-369, 2024 Mar 18.
Article in En | MEDLINE | ID: mdl-38525706
ABSTRACT

BACKGROUND:

Headache disorders have been associated with anxiety and depressive disorders. The aim of this study was to assess symptoms of anxiety and depression in a large sample of individuals with different headache disorders (HDs) in order to determine whether their frequency differs by headache type.

METHODS:

Consecutive individuals with headache attending a headache outpatient clinic were interviewed with the HAM-D and HAM-A, along with age, sex, and education matched non-headache individuals.

RESULTS:

Individuals numbering 2673 with headache (females 71.2%) and 464 non-headache individuals (females 70.9%) were interviewed (with participation rates of 98.3% and 91.0%, respectively). Migraine was diagnosed in 49.7%, tension-type headache in 38%, cluster headache 5.2%, and medication overuse (MO) in 21.8%. Participants with HD scored more in HAM-A (OR = 4.741, CI95% 3.855-5.831, p < 0.001) and HAM-D scales (OR = 2.319, CI95% 1.892-2.842, p < 0.001) than non-headache individuals. Participants with chronic HDs (≥15 days with headache for ≥3 consecutive months; 52.5%) scored higher for both HAM-A (OR = 1.944, CI95% 1.640-2.303, p < 0.001) and HAM-D (OR = 1.625, CI95% 1.359-1.944, p < 0.001) than those with episodic HDs (33.1%), as did participants with MO vs. participants without MO (OR = 3.418, CI95% 2.655-4.399, p < 0.001 for HAM-A, OR = 3.043, CI95% 2.322-3.986, p < 0.001 for HAM-D). Female and low-educated participants scored higher on both scales.

CONCLUSION:

Because symptoms of anxiety and depression are substantial in people with HD, the treating physicians should look out for such symptoms and manage them appropriately.
Key words